Bloomios

Bloomios Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Bloomios (BLMS) as of Oct 28, 2026 is -22.44. In the previous year, Cash Conversion Cycle (CCC) was -131.27 — a change of -82.90% (higher).

Cash Conversion Cycle

-22.44

YoY

-82.90%

Last updated:

Cash Conversion Cycle (CCC) of Bloomios is 2022 -22.44 . Cash Conversion Cycle (CCC) of Bloomios was 2021 -131.27 . It decreases by -82.90% higher compared to the previous year.

The Bloomios Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2020
-570.74 USD
Jan 1, 2021
-131.27 USD
Jan 1, 2022
-22.44 USD
The Bloomios Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-22.44-82.90%
-131.27-77.00%
-570.74—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bloomios Stock analysis

What does Bloomios do? Bloomios, Inc. generates revenue through the wholesale distribution of U.S. hemp-derived supplements and cosmetic products. The company manufactures and distributes hemp-infused edibles, pet edibles, tinctures, shots, topicals, smokable hemp, and other products across seven categories including edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. BPL, a subsidiary of Bloomios, focuses on manufacturing and distributing hemp-derived nootropic and nutraceutical products to wholesalers and retailers. Bloomios provides private-label and white-label services with over 80 customizable products and custom formulation and manufacturing support for its customers. The company's primary customers are wholesalers and retailers who purchase its hemp-derived products for resale. Bloomios offers a comprehensive suite of services including custom formulation, order fulfillment, and brand development to support its clients. Its product portfolio spans multiple categories such as human edibles, pet edibles, liquid consumables, topicals, and smokable hemp, catering to both consumer and pet markets. Bloomios leverages its subsidiary BPL to expand its product offerings in the hemp-derived nootropic and nutraceutical sectors. The company's focus on customizable solutions allows it to serve a diverse range of clients seeking private-label and white-label hemp products. Through its wholesale distribution channels, Bloomios targets businesses looking to sell hemp-based supplements and cosmetics under their own brand names. Bloomios is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bloomios stock

Cash Conversion Cycle (CCC) of Bloomios is -22.44 in 2022.

Cash Conversion Cycle (CCC) of Bloomios changed from -131.27 to -22.44, representing a -82.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Bloomios since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Bloomios with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bloomios

All Key Metrics — Bloomios